Quell Therapeutics raised €138M in a Series B round in Nov 2021. The company is based in London, UK. Investors in the round: British Patient Capital, Fidelity Management & Research Company LLC, Janus Henderson Investors and 7 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
